Yahoo
NasdaqCM - Delayed Quote USD

HeartBeam, Inc. (BEAT)

0.4993 -0.0905 (-15.34%)
At close: August 14 at 4:00:01 PM EDT
0.4969 -0.0024 (-0.48%)
After hours: August 14 at 7:42:40 PM EDT
BEAT Q2 2026 earnings call
Replay the call for the latest insights.
Chart Range Bar
Loading chart for BEAT
  • Previous Close 0.5898
  • Open 0.5600
  • Bid 0.4000 x 200
  • Ask 0.7517 x 200
  • Day's Range 0.4913 - 0.5751
  • 52 Week Range 0.4810 - 4.0000
  • Volume 1,070,074
  • Avg. Volume 745,301
  • Market Cap (intraday) 28.135M
  • Beta (5Y Monthly) -0.79
  • PE Ratio (TTM) --
  • EPS (TTM) -0.4400
  • Earnings Date (est.) Nov 12, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 3.38

HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card sized 3D ECG recording device, a patient application, a physician portal, and powerful cloud-based algorithms. HeartBeam, Inc. was incorporated in 2015 and is based in Santa Clara, California.

www.heartbeam.com

17

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Performance Overview

Trailing total returns as of 8/14/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

BEAT
79.20%
S&P 500 (^GSPC)
13.74%

1-Year Return

BEAT
55.02%
S&P 500 (^GSPC)
20.36%

3-Year Return

BEAT
80.80%
S&P 500 (^GSPC)
73.41%

5-Year Return

BEAT
90.75%
S&P 500 (^GSPC)
74.26%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue --
Earnings -4.7M

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

-5M
-4M
-3M
-2M
-1M
0

Analyst Insights

View More

Analyst Price Targets

2.00
3.38 Average
0.4993 Current
5.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 7/14/2026
Analyst Maxim Group
Rating Action Initiated
Rating Buy
Price Action Announces
Price Target 2

Statistics

View More

Valuation Measures

Annual
As of 8/10/2026
  • Market Cap

    30.46M

  • Enterprise Value

    28.42M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    47.97

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -195.14%

  • Return on Equity (ttm)

    -495.62%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -20.23M

  • Diluted EPS (ttm)

    -0.4400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.04M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -6.48M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

0.4993 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: